Empagliflozin
6 NDCs across 1 manufacturer|0 Generic,6 Brand
Empagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 1, 2014, and the first generic was approved Aug 3, 2022. In 2024, Medicare Part D spent $11.4 billion on Empagliflozin across 11.4 million claims for 2.5 million beneficiaries.
Empagliflozin is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $11.19 to $11.19 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
1
competing in market
Price Spread
$11.19 – $11.19
per EA
7d Activity
avg -0.1% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing EMPAGLIFLOZIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
JARDIANCE 10 MG TABLET | $11.1882 per EA | -0.04% |
JARDIANCE 10 MG TABLET | $11.1882 per EA | -0.04% |
JARDIANCE 10 MG TABLET | $11.1882 per EA | -0.04% |
JARDIANCE 25 MG TABLET | $11.1858 per EA | -0.08% |
JARDIANCE 25 MG TABLET | $11.1858 per EA | -0.08% |
JARDIANCE 25 MG TABLET | $11.1858 per EA | -0.08% |
Frequently Asked Questions
What is Empagliflozin used to treat?
Empagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Empagliflozin become available as a generic?
FDA approved the first generic Empagliflozin (ANDA) on Aug 3, 2022.
How much does Medicare spend on Empagliflozin?
In 2024, Medicare Part D spent $11.4 billion on Empagliflozin across 11.4 million claims for 2.5 million beneficiaries.
How many Empagliflozin products are on the market?
The Empagliflozin drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.
What is the price range for Empagliflozin?
NADAC reference prices for Empagliflozin range from $11.1858 to $11.1882 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Empagliflozin?
1 manufacturer lists Empagliflozin in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (6).
How has the price of Empagliflozin changed recently?
Over the past 7 days, 0 Empagliflozin NDCs rose and 6 fell, with a market-wide average change of -0.1%.